Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Aprepitant Capsules Market Research Report 2025

Global Aprepitant Capsules Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-01

Pages: 87 Pages

Report ld: 3445416

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Aprepitant Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.

Aprepitant capsules are widely used for the prevention of nausea and vomiting during both the induction and subsequent phases of chemotherapy. With the continuous evolution of the oncology field, Aprepitant capsules have solidified their position in the market, leading to a gradual expansion of its market size. Its outstanding clinical performance has resulted in sustained sales growth, establishing it as a key player in the management of nausea and vomiting. Furthermore, as research into supportive therapies for cancer treatment advances, Aprepitant capsules hold the potential for further application and development in a broader spectrum of nausea and vomiting prevention, ultimately offering enhanced quality of life for patients.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Aprepitant Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant Capsules.

The Aprepitant Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aprepitant Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aprepitant Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Merck

Sandoz

Glenmark Pharmaceuticals

Chia Tai Tianqing Pharmaceutical Group

Qilu Pharmaceutical

Camber Pharma

Segment by Type

80mg

125mg

Other

Segment by Application

Hospital

Pharmacy

Other

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Aprepitant Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Aprepitant Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Aprepitant Capsules Market Overview

1.1 Product Definition

1.2 Aprepitant Capsules by Type

1.2.1 Global Aprepitant Capsules Market Value Comparison by Type (2024 VS 2031)

1.2.2 80mg

1.2.3 125mg

1.2.4 Other

1.3 Aprepitant Capsules by Application

1.3.1 Global Aprepitant Capsules Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Aprepitant Capsules Market Size Estimates and Forecasts

1.4.1 Global Aprepitant Capsules Revenue 2020-2031

1.4.2 Global Aprepitant Capsules Sales 2020-2031

1.4.3 Global Aprepitant Capsules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Aprepitant Capsules Market Competition by Manufacturers

2.1 Global Aprepitant Capsules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Aprepitant Capsules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Aprepitant Capsules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Aprepitant Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Aprepitant Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Aprepitant Capsules, Product Type & Application

2.7 Global Key Manufacturers of Aprepitant Capsules, Date of Enter into This Industry

2.8 Global Aprepitant Capsules Market Competitive Situation and Trends

2.8.1 Global Aprepitant Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Aprepitant Capsules Players Market Share by Revenue

2.8.3 Global Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Aprepitant Capsules Market Scenario by Region

3.1 Global Aprepitant Capsules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Aprepitant Capsules Sales by Region: 2020-2031

3.2.1 Global Aprepitant Capsules Sales by Region: 2020-2025

3.2.2 Global Aprepitant Capsules Sales by Region: 2026-2031

3.3 Global Aprepitant Capsules Revenue by Region: 2020-2031

3.3.1 Global Aprepitant Capsules Revenue by Region: 2020-2025

3.3.2 Global Aprepitant Capsules Revenue by Region: 2026-2031

3.4 North America Aprepitant Capsules Market Facts & Figures by Country

3.4.1 North America Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Aprepitant Capsules Sales by Country (2020-2031)

3.4.3 North America Aprepitant Capsules Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Aprepitant Capsules Market Facts & Figures by Country

3.5.1 Europe Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Aprepitant Capsules Sales by Country (2020-2031)

3.5.3 Europe Aprepitant Capsules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Aprepitant Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Aprepitant Capsules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Aprepitant Capsules Sales by Region (2020-2031)

3.6.3 Asia Pacific Aprepitant Capsules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Aprepitant Capsules Market Facts & Figures by Country

3.7.1 Latin America Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Aprepitant Capsules Sales by Country (2020-2031)

3.7.3 Latin America Aprepitant Capsules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Aprepitant Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Aprepitant Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Aprepitant Capsules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Aprepitant Capsules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Aprepitant Capsules Sales by Type (2020-2031)

4.1.1 Global Aprepitant Capsules Sales by Type (2020-2025)

4.1.2 Global Aprepitant Capsules Sales by Type (2026-2031)

4.1.3 Global Aprepitant Capsules Sales Market Share by Type (2020-2031)

4.2 Global Aprepitant Capsules Revenue by Type (2020-2031)

4.2.1 Global Aprepitant Capsules Revenue by Type (2020-2025)

4.2.2 Global Aprepitant Capsules Revenue by Type (2026-2031)

4.2.3 Global Aprepitant Capsules Revenue Market Share by Type (2020-2031)

4.3 Global Aprepitant Capsules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Aprepitant Capsules Sales by Application (2020-2031)

5.1.1 Global Aprepitant Capsules Sales by Application (2020-2025)

5.1.2 Global Aprepitant Capsules Sales by Application (2026-2031)

5.1.3 Global Aprepitant Capsules Sales Market Share by Application (2020-2031)

5.2 Global Aprepitant Capsules Revenue by Application (2020-2031)

5.2.1 Global Aprepitant Capsules Revenue by Application (2020-2025)

5.2.2 Global Aprepitant Capsules Revenue by Application (2026-2031)

5.2.3 Global Aprepitant Capsules Revenue Market Share by Application (2020-2031)

5.3 Global Aprepitant Capsules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Aprepitant Capsules Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Sandoz

6.2.1 Sandoz Company Information

6.2.2 Sandoz Description and Business Overview

6.2.3 Sandoz Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sandoz Aprepitant Capsules Product Portfolio

6.2.5 Sandoz Recent Developments/Updates

6.3 Glenmark Pharmaceuticals

6.3.1 Glenmark Pharmaceuticals Company Information

6.3.2 Glenmark Pharmaceuticals Description and Business Overview

6.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Glenmark Pharmaceuticals Aprepitant Capsules Product Portfolio

6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates

6.4 Chia Tai Tianqing Pharmaceutical Group

6.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information

6.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview

6.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Portfolio

6.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates

6.5 Qilu Pharmaceutical

6.5.1 Qilu Pharmaceutical Company Information

6.5.2 Qilu Pharmaceutical Description and Business Overview

6.5.3 Qilu Pharmaceutical Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Qilu Pharmaceutical Aprepitant Capsules Product Portfolio

6.5.5 Qilu Pharmaceutical Recent Developments/Updates

6.6 Camber Pharma

6.6.1 Camber Pharma Company Information

6.6.2 Camber Pharma Description and Business Overview

6.6.3 Camber Pharma Aprepitant Capsules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Camber Pharma Aprepitant Capsules Product Portfolio

6.6.5 Camber Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Aprepitant Capsules Industry Chain Analysis

7.2 Aprepitant Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Aprepitant Capsules Production Mode & Process Analysis

7.4 Aprepitant Capsules Sales and Marketing

7.4.1 Aprepitant Capsules Sales Channels

7.4.2 Aprepitant Capsules Distributors

7.5 Aprepitant Capsules Customer Analysis

8 Aprepitant Capsules Market Dynamics

8.1 Aprepitant Capsules Industry Trends

8.2 Aprepitant Capsules Market Drivers

8.3 Aprepitant Capsules Market Challenges

8.4 Aprepitant Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Aprepitant Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Aprepitant Capsules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Aprepitant Capsules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Aprepitant Capsules Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Aprepitant Capsules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Aprepitant Capsules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Aprepitant Capsules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Aprepitant Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Aprepitant Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Aprepitant Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Aprepitant Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Aprepitant Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Aprepitant Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant Capsules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Aprepitant Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Aprepitant Capsules Sales by Region (2020-2025) & (K Units)

Table 18. Global Aprepitant Capsules Sales Market Share by Region (2020-2025)

Table 19. Global Aprepitant Capsules Sales by Region (2026-2031) & (K Units)

Table 20. Global Aprepitant Capsules Sales Market Share by Region (2026-2031)

Table 21. Global Aprepitant Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Aprepitant Capsules Revenue Market Share by Region (2020-2025)

Table 23. Global Aprepitant Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Aprepitant Capsules Revenue Market Share by Region (2026-2031)

Table 25. North America Aprepitant Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Aprepitant Capsules Sales by Country (2020-2025) & (K Units)

Table 27. North America Aprepitant Capsules Sales by Country (2026-2031) & (K Units)

Table 28. North America Aprepitant Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Aprepitant Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Aprepitant Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Aprepitant Capsules Sales by Country (2020-2025) & (K Units)

Table 32. Europe Aprepitant Capsules Sales by Country (2026-2031) & (K Units)

Table 33. Europe Aprepitant Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Aprepitant Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Aprepitant Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Aprepitant Capsules Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Aprepitant Capsules Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Aprepitant Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Aprepitant Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Aprepitant Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Aprepitant Capsules Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Aprepitant Capsules Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Aprepitant Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Aprepitant Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Aprepitant Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Aprepitant Capsules Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Aprepitant Capsules Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Aprepitant Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Aprepitant Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Aprepitant Capsules Sales (K Units) by Type (2020-2025)

Table 51. Global Aprepitant Capsules Sales (K Units) by Type (2026-2031)

Table 52. Global Aprepitant Capsules Sales Market Share by Type (2020-2025)

Table 53. Global Aprepitant Capsules Sales Market Share by Type (2026-2031)

Table 54. Global Aprepitant Capsules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Aprepitant Capsules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Aprepitant Capsules Revenue Market Share by Type (2020-2025)

Table 57. Global Aprepitant Capsules Revenue Market Share by Type (2026-2031)

Table 58. Global Aprepitant Capsules Price (US$/Unit) by Type (2020-2025)

Table 59. Global Aprepitant Capsules Price (US$/Unit) by Type (2026-2031)

Table 60. Global Aprepitant Capsules Sales (K Units) by Application (2020-2025)

Table 61. Global Aprepitant Capsules Sales (K Units) by Application (2026-2031)

Table 62. Global Aprepitant Capsules Sales Market Share by Application (2020-2025)

Table 63. Global Aprepitant Capsules Sales Market Share by Application (2026-2031)

Table 64. Global Aprepitant Capsules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Aprepitant Capsules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Aprepitant Capsules Revenue Market Share by Application (2020-2025)

Table 67. Global Aprepitant Capsules Revenue Market Share by Application (2026-2031)

Table 68. Global Aprepitant Capsules Price (US$/Unit) by Application (2020-2025)

Table 69. Global Aprepitant Capsules Price (US$/Unit) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck Aprepitant Capsules Product

Table 74. Merck Recent Developments/Updates

Table 75. Sandoz Company Information

Table 76. Sandoz Description and Business Overview

Table 77. Sandoz Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Sandoz Aprepitant Capsules Product

Table 79. Sandoz Recent Developments/Updates

Table 80. Glenmark Pharmaceuticals Company Information

Table 81. Glenmark Pharmaceuticals Description and Business Overview

Table 82. Glenmark Pharmaceuticals Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Glenmark Pharmaceuticals Aprepitant Capsules Product

Table 84. Glenmark Pharmaceuticals Recent Developments/Updates

Table 85. Chia Tai Tianqing Pharmaceutical Group Company Information

Table 86. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview

Table 87. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product

Table 89. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates

Table 90. Qilu Pharmaceutical Company Information

Table 91. Qilu Pharmaceutical Description and Business Overview

Table 92. Qilu Pharmaceutical Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Qilu Pharmaceutical Aprepitant Capsules Product

Table 94. Qilu Pharmaceutical Recent Developments/Updates

Table 95. Camber Pharma Company Information

Table 96. Camber Pharma Description and Business Overview

Table 97. Camber Pharma Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Camber Pharma Aprepitant Capsules Product

Table 99. Camber Pharma Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Aprepitant Capsules Distributors List

Table 103. Aprepitant Capsules Customers List

Table 104. Aprepitant Capsules Market Trends

Table 105. Aprepitant Capsules Market Drivers

Table 106. Aprepitant Capsules Market Challenges

Table 107. Aprepitant Capsules Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Aprepitant Capsules

Figure 2. Global Aprepitant Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Aprepitant Capsules Market Share by Type: 2024 & 2031

Figure 4. 80mg Product Picture

Figure 5. 125mg Product Picture

Figure 6. Other Product Picture

Figure 7. Global Aprepitant Capsules Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Aprepitant Capsules Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Other

Figure 12. Global Aprepitant Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Aprepitant Capsules Market Size (2020-2031) & (US$ Million)

Figure 14. Global Aprepitant Capsules Sales (2020-2031) & (K Units)

Figure 15. Global Aprepitant Capsules Average Price (US$/Unit) & (2020-2031)

Figure 16. Aprepitant Capsules Report Years Considered

Figure 17. Aprepitant Capsules Sales Share by Manufacturers in 2024

Figure 18. Global Aprepitant Capsules Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Aprepitant Capsules Players: Market Share by Revenue in Aprepitant Capsules in 2024

Figure 20. Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Aprepitant Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Aprepitant Capsules Sales Market Share by Country (2020-2031)

Figure 23. North America Aprepitant Capsules Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Aprepitant Capsules Sales Market Share by Country (2020-2031)

Figure 27. Europe Aprepitant Capsules Revenue Market Share by Country (2020-2031)

Figure 28. Germany Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Aprepitant Capsules Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Aprepitant Capsules Revenue Market Share by Region (2020-2031)

Figure 35. China Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Aprepitant Capsules Sales Market Share by Country (2020-2031)

Figure 46. Latin America Aprepitant Capsules Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Aprepitant Capsules Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Aprepitant Capsules Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Aprepitant Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Aprepitant Capsules by Type (2020-2031)

Figure 56. Global Revenue Market Share of Aprepitant Capsules by Type (2020-2031)

Figure 57. Global Aprepitant Capsules Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Aprepitant Capsules by Application (2020-2031)

Figure 59. Global Revenue Market Share of Aprepitant Capsules by Application (2020-2031)

Figure 60. Global Aprepitant Capsules Price (US$/Unit) by Application (2020-2031)

Figure 61. Aprepitant Capsules Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Aprepitant Capsules market? zhanKai

The top companies in the global Aprepitant Capsules market are Merck、Sandoz、Glenmark Pharmaceuticals.

Related Reports

Global Aprepitant Capsules Market Insights, Forecast to 2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-04-12
Pages: 90
USD 4900.00
(Single User License)
Global Aprepitant Capsules Market Research Report 2024
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-01-17
Pages: 77
USD 2900.00
(Single User License)
Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-01-10
Pages: 105
USD 3950.00
(Single User License)

Global Aprepitant Capsules Market Insights, Forecast to 2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-04-12
Pages: 90
USD 4900.00 (Single User License)
Global Aprepitant Capsules Market Research Report 2024
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-01-17
Pages: 77
USD 2900.00 (Single User License)
Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-01-10
Pages: 105
USD 3950.00 (Single User License)